本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

128.41
-3.0300-2.31%
盘后128.40-0.0100-0.01%19:45 EDT
成交量:103.04万
成交额:1.33亿
市值:128.88亿
市盈率:27.50
高:131.71
开:131.00
低:127.76
收:131.44
52周最高:160.18
52周最低:97.30
股本:1.00亿
流通股本:9,800.26万
量比:1.04
换手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):4.67
每股收益(LYR):4.67
净资产收益率:16.38%
总资产收益率:9.53%
市净率:3.96
市盈率(LYR):27.50

数据加载中...

2021/04/16

重要事件披露

8-K - Current report
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report
2020/11/24

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/09/10

重要事件披露

8-K - Current report
2020/08/28

重要事件披露

8-K - Current report
2020/08/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments